CompletedPhase 1Phase 2

Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation

NCT03047629

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Keck Hospital of University of Southern California

Los Angeles, California, United States

+14 additional locations

Save this trial

Keck Hospital of University of Southern CaliforniaLos Angeles, California, United States
Rocky Mountain Movement Disorders Center, PCEnglewood, Colorado, United States
Georgetown Universtiy, Department of NeurologyWashington D.C., District of Columbia, United States
Parkinson's Disease and Movement Disorders Center of Boca RatonBoca Raton, Florida, United States
Neuroscience Research, University of Florida JacksonvilleJacksonville, Florida, United States
MEDSOL Clinical ResearchPort Charlotte, Florida, United States
Sarasota Memory Hospital Clinical Research Ctr.Sarasota, Florida, United States
Suncoast Neuroscience Associates, IncSt. Petersburg, Florida, United States
USF Health Byrd Parkinson's Disease Movement Disorders Center of ExcellenceTampa, Florida, United States
Quest Research InstituteFarmington Hills, Michigan, United States
Movement Disorders Division, Mt. Sinai School of MedicineNew York, New York, United States
Riverhills Healthcare, Inc.Cincinnati, Ohio, United States
Parkinson's & Movement Disorders Center, UH Cleveland Medical CenterCleveland, Ohio, United States
Penn State Health, Department of NeurologyHershey, Pennsylvania, United States
Thomas Jefferson University, Department of NeurologyPhiladelphia, Pennsylvania, United States